documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
33 rows where docket_id = "FDA-2008-N-0326" sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: subtype, posted_date, posted_month, comment_start_date, comment_end_date, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)
document_type 3
agency_id 1
- FDA 33
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2008-N-0326-0348 | FDA | None FDA-2008-N-0326 | Reference 12 - New England Journal of Medicine, Mechanism of Disease The New B-Lactamases re New Animal Drugs; Cephalosporin Drugs; Extralabel Animal Drug Use; Order of Prohibition, FDA-2008-N-0326-0001 - Background | Supporting & Related Material | Background Material | 2012-07-04T04:00:00Z | 2012 | 7 | 2012-07-04T16:54:14Z | 0 | 0 | 090000648064e653 | |||
| FDA-2008-N-0326-0346 | FDA | None FDA-2008-N-0326 | References (Pfizer - Comment) re FDA-2008-N-0326-0165 - Background | Supporting & Related Material | Background Material | 2012-07-04T04:00:00Z | 2012 | 7 | 2012-07-04T15:15:48Z | 0 | 0 | 0900006480788190 | |||
| FDA-2008-N-0326-0345 | FDA | None FDA-2008-N-0326 | Office of the Executive Secretariat (OES) Response to Council of State Territorial Epidemiologists (CSTE) - Letter re FDA-2008-N-0326-0333 | Other | Letter(s) | 2012-07-03T04:00:00Z | 2012 | 7 | 2012-07-04T15:49:08Z | 0 | 0 | 09000064810121c1 | |||
| FDA-2008-N-0326-0338 | FDA | None FDA-2008-N-0326 | See FDA-2008-N-0326-0302 | Supporting & Related Material | Reference (external attachments) | 2012-04-18T04:00:00Z | 2012 | 4 | 2012-04-24T21:16:10Z | 0 | 0 | 0900006480fd8b41 | |||
| FDA-2008-N-0326-0333 | FDA | None FDA-2008-N-0326 | See FDA-2008-N-0326-0344 | Supporting & Related Material | Background Material | 2012-03-29T04:00:00Z | 2012 | 3 | 2012-07-04T15:53:44Z | 0 | 0 | 0900006480fe3bfb | |||
| FDA-2008-N-0326-0269 | FDA | None FDA-2008-N-0326 | American Academy of Pediatrics re FDA-2008-N-0326-0268 | Supporting & Related Material | Reference (external attachments) | 2012-03-06T05:00:00Z | 2012 | 3 | 2012-03-06T16:28:40Z | 0 | 0 | 0900006480fcb04e | |||
| FDA-2008-N-0326-0283 | FDA | None FDA-2008-N-0326 | The Veterinary Pharmacy (TVP), Inc. - Request for Extension | Other | Request for Extension | 2012-03-06T05:00:00Z | 2012 | 3 | 2012-01-06T05:00:00Z | 2012-03-07T04:59:59Z | 2012-03-08T20:13:45Z | 0 | 0 | 0900006480fcf456 | |
| FDA-2008-N-0326-0177 | FDA | None FDA-2008-N-0326 | New Animal Drugs; Orders of Prohibition: Cephalosporin Drugs; Extralabel Animal Drug Use | Rule | Final Rule | 2012-01-06T05:00:00Z | 2012 | 1 | 2012-01-06T05:00:00Z | 2012-03-07T04:59:59Z | 2012-07-05T02:01:56Z | 2012-00035 | 0 | 0 | 0900006480f8ecbc |
| FDA-2008-N-0326-0176 | FDA | None FDA-2008-N-0326 | New Animal Drugs; Cephalosporin Drugs; Extralabel Animal Drug Use; Revocation of Order of Prohibition; Withdrawal | Rule | NWL-Notice of Withdrawl | 2008-11-26T05:00:00Z | 2008 | 11 | 2008-11-26T05:00:00Z | 2008-12-20T16:26:21Z | E8-28093 | 0 | 0 | 09000064807c1087 | |
| FDA-2008-N-0326-0172 | FDA | None FDA-2008-N-0326 | Attachment 2 - Executive Summary and Reference List 1-16, 8-41 (Pfizer - Comment) re FDA-2008-N-0326-0165 and FDA-2008-N-0326-0346 | Supporting & Related Material | Background Material | 2008-11-04T05:00:00Z | 2008 | 11 | 2012-07-04T15:30:52Z | 0 | 0 | 09000064807940aa | |||
| FDA-2008-N-0326-0173 | FDA | None FDA-2008-N-0326 | See FDA-2008-N-0326-0116 (American College of Poultry Veterinarians - Comment) | Supporting & Related Material | Background Material | 2008-11-04T05:00:00Z | 2008 | 11 | 2012-07-04T17:00:54Z | 0 | 0 | 0900006480794057 | |||
| FDA-2008-N-0326-0051 | FDA | None FDA-2008-N-0326 | Sample Write-In Campaign 1 [Multiple Submitters=6] - Form Letter Comment | Other | FL-Form Letter | 2008-08-18T04:00:00Z | 2008 | 8 | 2008-08-18T04:00:00Z | 2012-03-07T17:19:37Z | 0 | 0 | 09000064806caf24 | ||
| FDA-2008-N-0326-0049 | FDA | None FDA-2008-N-0326 | New Animal Drugs; Cephalosporin Drugs; Extralabel Animal Drug Use; Order of Prohibition; Extension of Comment Period; Delay of Effective Date of Final Rule | Rule | Delay of Effective Date | 2008-08-18T04:00:00Z | 2008 | 8 | 2008-08-18T04:00:00Z | 2008-11-04T04:59:59Z | 2012-01-27T23:43:15Z | E8-18967 | 0 | 0 | 09000064806ca625 |
| FDA-2008-N-0326-0036 | FDA | None FDA-2008-N-0326 | American Association of Small Ruminant Practitioner - Request for Extension Comment Due Date | Other | EXT-Request for Extension Comment Due Date | 2008-08-10T04:00:00Z | 2008 | 8 | 2008-08-10T04:00:00Z | 2008-08-10T22:23:19Z | 0 | 0 | 09000064806b7ab7 | ||
| FDA-2008-N-0326-0029 | FDA | None FDA-2008-N-0326 | American Association of Bovine Practitioners - Request for Extension Comment Due Date | Other | EXT-Request for Extension Comment Due Date | 2008-08-05T04:00:00Z | 2008 | 8 | 2008-08-05T04:00:00Z | 2013-07-27T22:19:07Z | 0 | 0 | 090000648068cb7f | ||
| FDA-2008-N-0326-0025 | FDA | None FDA-2008-N-0326 | American Association of Bovine Practitioners - Request for Extension Comment Due Date | Other | EXT-Request for Extension Comment Due Date | 2008-07-22T04:00:00Z | 2008 | 7 | 2008-07-22T04:00:00Z | 2013-08-11T04:27:03Z | 0 | 0 | 090000648068d52e | ||
| FDA-2008-N-0326-0026 | FDA | None FDA-2008-N-0326 | Pfizer, Inc. - Request for Extension Comment Due Date | Other | EXT-Request for Extension Comment Due Date | 2008-07-22T04:00:00Z | 2008 | 7 | 2008-07-22T04:00:00Z | 2013-07-27T22:19:18Z | 0 | 0 | 090000648068d596 | ||
| FDA-2008-N-0326-0024 | FDA | None FDA-2008-N-0326 | Animal Health Institute - Request for Extension Comment Due Date | Other | EXT-Request for Extension Comment Due Date | 2008-07-22T04:00:00Z | 2008 | 7 | 2008-07-22T04:00:00Z | 2013-07-27T22:18:59Z | 0 | 0 | 0900006480685084 | ||
| FDA-2008-N-0326-0023 | FDA | None FDA-2008-N-0326 | American Veterinary Medical Association - Request for Extension Comment Due Date | Other | EXT-Request for Extension Comment Due Date | 2008-07-18T04:00:00Z | 2008 | 7 | 2008-07-18T04:00:00Z | 2013-07-27T22:18:53Z | 0 | 0 | 090000648067ffa0 | ||
| FDA-2008-N-0326-0001 | FDA | None FDA-2008-N-0326 | New Animal Drugs; Cephalosporin Drugs; Extralabel Animal Drug Use; Order of Prohibition | Rule | NFR-Notice of Final Rule | 2008-07-03T04:00:00Z | 2008 | 7 | 2008-07-03T04:00:00Z | 2008-09-04T03:59:59Z | 2012-07-05T02:02:01Z | E8-15052 | 0 | 0 | 0900006480653961 |
| FDA-2008-N-0326-0008 | FDA | None FDA-2008-N-0326 | Reference 7 - CDC, National Antimicrobial Resistance Monitoring System for Enteric Bacteria (NARMS): Human Isolates Final Report, 2004 re New Animal Drugs; Cephalosporin Drugs; Extralabel Animal Drug Use; Order of Prohibition, FDA-2008-N-0326-0001 - Background | Supporting & Related Material | Background Material | 2008-07-03T04:00:00Z | 2008 | 7 | 2012-07-04T16:56:03Z | 0 | 0 | 090000648064e468 | |||
| FDA-2008-N-0326-0011 | FDA | None FDA-2008-N-0326 | Reference 10 - Clinical & Laboratory Standards Institute, Performance Standards for Antimicrobial Susceptibility Testing re New Animal Drugs; Cephalosporin Drugs; Extralabel Animal Drug Use; Order of Prohibition, FDA-2008-N-0326-0001 - Background | Supporting & Related Material | Background Material | 2008-07-03T04:00:00Z | 2008 | 7 | 2012-07-04T16:56:46Z | 0 | 0 | 090000648064e62b | |||
| FDA-2008-N-0326-0004 | FDA | None FDA-2008-N-0326 | Reference 3 - B-Lactam Resistance & B-lactamases in Bacteria of Animal Origin re New Animal Drugs; Cephalosporin Drugs; Extralabel Animal Drug Use; Order of Prohibition, FDA-2008-N-0326-0001 - Background | Supporting & Related Material | Background Material | 2008-07-03T04:00:00Z | 2008 | 7 | 2012-07-04T16:55:08Z | 0 | 0 | 090000648064e439 | |||
| FDA-2008-N-0326-0005 | FDA | None FDA-2008-N-0326 | Reference 4 - EARSS Annual Report 2005 Pages 1-147 2006 Bilthoven, The Netherlands, European Antimicrobial Resistance Surveillance System re New Animal Drugs; Cephalosporin Drugs; Extralabel Animal Drug Use; Order of Prohibition, FDA-2008-N-0326-0001 - Background | Supporting & Related Material | Background Material | 2008-07-03T04:00:00Z | 2008 | 7 | 2012-07-04T16:55:22Z | 0 | 0 | 090000648064e441 | |||
| FDA-2008-N-0326-0010 | FDA | None FDA-2008-N-0326 | Reference 9 - American Society for Microbiology, B-Lactamaces in Laboratory & Clinical Resistance re New Animal Drugs; Cephalosporin Drugs; Extralabel Animal Drug Use; Order of Prohibition, FDA-2008-N-0326-0001 - Background | Supporting & Related Material | Background Material | 2008-07-03T04:00:00Z | 2008 | 7 | 2012-07-04T16:56:34Z | 0 | 0 | 090000648064e61f | |||
| FDA-2008-N-0326-0014 | FDA | None FDA-2008-N-0326 | List of References re New Animal Drugs; Cephalosporin Drugs; Extralabel Animal Drug Use; Order of Prohibition, FDA-2008-N-0326-0001 - Background | Supporting & Related Material | Background Material | 2008-07-03T04:00:00Z | 2008 | 7 | 2012-07-04T16:57:28Z | 0 | 0 | 0900006480654597 | |||
| FDA-2008-N-0326-0009 | FDA | None FDA-2008-N-0326 | Reference 8 - American Society for Microbiology, DNA Sequence Analysis of Regions Surrounding blacmy-2 from Multiple Salmonella Plasmid Backbones re New Animal Drugs; Cephalosporin Drugs; Extralabel Animal Drug Use; Order of Prohibition, FDA-2008-N-0326-0001 - Background | Supporting & Related Material | Background Material | 2008-07-03T04:00:00Z | 2008 | 7 | 2012-07-04T16:56:13Z | 0 | 0 | 090000648064e603 | |||
| FDA-2008-N-0326-0002 | FDA | None FDA-2008-N-0326 | Reference 1 - Williams et al Antibiotics in Laboratory Medicine re New Animal Drugs; Cephalosporin Drugs; Extralabel Animal Drug Use; Order of Prohibition, FDA-2008-N-0326-0001 - Background | Supporting & Related Material | Background Material | 2008-07-03T04:00:00Z | 2008 | 7 | 2012-07-04T16:54:43Z | 0 | 0 | 090000648064e32d | |||
| FDA-2008-N-0326-0007 | FDA | None FDA-2008-N-0326 | Reference 6 - CDC Enteric Disease Branch, Animal-to-man Transmission of Antimicrobial-resistant Salmonella: Investigations of United States Outbreaks, 1971-1983 re New Animal Drugs; Cephalosporin Drugs; Extralabel Animal Drug Use; Order of Prohibition, FDA-2008-N-0326-0001 - Background | Supporting & Related Material | Background Material | 2008-07-03T04:00:00Z | 2008 | 7 | 2012-07-04T16:55:50Z | 0 | 0 | 090000648064e45d | |||
| FDA-2008-N-0326-0003 | FDA | None FDA-2008-N-0326 | Reference 2 - US Food & Drug Administration, Maxipime (Cefepime Hydrochloride) for Injection, Powder, For Solution (Bristol-Myers Squibb) re New Animal Drugs; Cephalosporin Drugs; Extralabel Animal Drug Use; Order of Prohibition, FDA-2008-N-0326-0001 - Background | Supporting & Related Material | Background Material | 2008-07-03T04:00:00Z | 2008 | 7 | 2012-07-04T16:54:56Z | 0 | 0 | 090000648064e42a | |||
| FDA-2008-N-0326-0006 | FDA | None FDA-2008-N-0326 | Reference 5 - USDA/ARS National Antimicrobial Resistance Montoring System, Veterinary Isolates Data re New Animal Drugs; Cephalosporin Drugs; Extralabel Animal Drug Use; Order of Prohibition, FDA-2008-N-0326-0001 - Background | Supporting & Related Material | Background Material | 2008-07-03T04:00:00Z | 2008 | 7 | 2012-07-04T16:55:34Z | 0 | 0 | 090000648064e44b | |||
| FDA-2008-N-0326-0012 | FDA | None FDA-2008-N-0326 | Reference 11 - J. of Antimicrobial Chemotherapy, CTX-M: Changing the Face of ESBLs In Europe re New Animal Drugs; Cephalosporin Drugs; Extralabel Animal Drug Use; Order of Prohibition, FDA-2008-N-0326-0001 - Background | Supporting & Related Material | Background Material | 2008-07-03T04:00:00Z | 2008 | 7 | 2012-07-04T16:56:59Z | 0 | 0 | 090000648064e63a | |||
| FDA-2008-N-0326-0013 | FDA | None FDA-2008-N-0326 | Reference 13 - Summary of Data from Hatchery Inspections Conducted September-October, 2001 re New Animal Drugs; Cephalosporin Drugs; Extralabel Animal Drug Use; Order of Prohibition, FDA-2008-N-0326-0001 - Background | Supporting & Related Material | Background Material | 2008-07-03T04:00:00Z | 2008 | 7 | 2012-07-04T16:57:14Z | 0 | 0 | 090000648064e666 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;